Efficacy of long-acting growth hormone in Axenfeld-Rieger syndrome with a novel 3.824 Mb 4q25 deletion: a Case Report and systematic literature review
Shihui Guan, Jinyu Wang, Zhenxian Liu, Yangfan Qi, Xiaoyu Sun, Kai Jiang, Shuangzhu Lin · 2026
Read Efficacy of long-acting growth hormone in Axenfeld-Rieger syndrome with a novel 3.824 Mb 4q25 deletion: a Case Report and systematic literature review by Shihui Guan, Jinyu Wang, Zhenxian Liu, Yangfan Qi, Xiaoyu Sun, Kai Jiang, Shuangzhu Lin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13318242.txt.
Description
Shihui Guan and colleagues report a 2026 case of Axenfeld-Rieger syndrome, a multi-system disorder of eye and tooth development, in a young boy whose missing chromosome stretch also shut down growth hormone. Pairing the case with a literature review, they test whether deletion size predicts hormone failure.
Family gene sequencing in the 5.4-year-old found a fresh 3.824 megabase deletion at chromosome band 4q25, removing PITX2 and neighbors. His growth hormone peak was just 4.22 in stimulation testing, with bone age lagging by a year and a half. Twenty months on long-acting hormone therapy gained him 16.5 centimeters and restored a normal height range. Ten reviewed cases supported the size link. Growth checks, they urge, belong in routine care for deletion carriers.
Catalog record
| CREATOR | Shihui Guan, Jinyu Wang, Zhenxian Liu, Yangfan Qi, Xiaoyu Sun, Kai Jiang, Shuangzhu Lin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29596 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |